GL1X · GenesisL1 explorer

MolNFT v1 · #11555 · protein

Hcmv protease dimer-interface mutant, S225Y complexed to inhibitor bilc 408

1JQ7 · Assemblin: “Hcmv protease dimer-interface mutant, S225Y complexed to inhibitor bilc 408”. X-ray diffraction, 1 ligand (0FP), 5 pockets (best druggability 0.46). MolNFT v1 #11555 on GenesisL1: 3D structure, binding sites and pockets…

PDB
1JQ7
Type
protein
Length
427 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Assemblin
EC
3.4.21.97
UniProt
P16753
Ligands
0FP
Pockets
5 · best druggability 0.46

Structure

x-ray diffraction · 2 distinct chains · 31% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAssemblin (EC 3.4.21.97)protein21029% helix, 18% strandP16753
BAssemblin (EC 3.4.21.97)protein21734% helix, 21% strandP16753

Ligands and binding sites

  • 0FP · N-(6-aminohexanoyl)-3-methyl-L-valyl-3-methyl-L-valyl-N~1~-[(2S,3S)-3-hydroxy-4-oxo-4-{[(1R)-1-phenylpropyl]amino}butan-2-yl]-N~4~,N~4~-dimethyl-L-aspartamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11810.460.7530empty
2530.390.8115empty
3660.390.7919empty
4700.370.7815empty
5630.280.7313empty

Interfaces

1 interface between chains.

  • A–B · 1634 Ų buried · 32 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 1JQ7 · HCMV protease dimer-interface mutant, S225Y complexed to Inhibitor BILC 408 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.